Segment, Customer and Geographical Reporting (Tables)

3 Months Ended

Dec. 31, 2015

The Company’s segment information for the three months ended December 31, 2015 and 2014 is summarized below:

Results of Operations for the Three Months Ended December 31,
2015
				Contract
	Optics			Research			Biomedical		Total
Revenue	$	6,214,000		$	4,990,000		$	-	$	11,204,000
Gross Profit		2,110,000			1,855,000			-		3,965,000
GM %		34.0	%		37.2	%		-		35.4	%
SG&A		1,751,000			1,706,000			348,000		3,805,000
Gain on sale of assets		4,000			-			-		4,000
Operating Income (Loss)		363,000			149,000			(348,000)		164,000

Depreciation and Amortization		228,000			80,000			17,000		325,000
Capital expenditures		565,000			7,000			31,000		603,000

Intangibles, Net		644,000			256,000			297,000		1,197,000
Goodwill		1,155,000			4,939,000			-		6,094,000
Total Assets	$	16,506,000		$	8,273,000		$	857,000	$	25,636,000

Results of Operations for the Three Months Ended December 31,
2014
				Contract
	Optics			Research			Biomedical		Total
Revenue	$	4,948,000		$	4,663,000		$	-	$	9,611,000
Gross Profit		1,495,000			2,098,000			-		3,593,000
GM %		30.2	%		45.0	%		-		37.4	%
SG&A		2,091,000			1,881,000			235,000		4,207,000
Gain on sale of assets		185,000			-			-		185,000
Operating Income (Loss)		(410,000)			216,000			(235,000)		(429,000)

Depreciation and Amortization		204,000			74,000			15,000		293,000
Capital expenditures		244,000			-			-		244,000

Intangibles, Net		752,000			290,000			229,000		1,271,000
Goodwill		1,232,000			4,939,000			-		6,171,000
Total Assets	$	15,419,000		$	9,036,000		$	922,000	$	25,377,000

Revenue by geographic location in total and as a percentage of total revenue, for the three months ended December 31, 2015 and 2014 are as follows: